Academic
Publications
Factors affecting efficacy in patients with genotype 2 chronic hepatitis C treated by pegylated interferon alpha-2b and ribavirin: reducing drug doses has no impact on rapid and sustained virological responses

Factors affecting efficacy in patients with genotype 2 chronic hepatitis C treated by pegylated interferon alpha-2b and ribavirin: reducing drug doses

Factors affecting efficacy in patients with genotype 2 chronic hepatitis C treated by pegylated interferon alpha-2b and ribavirin: reducing drug doses has no impact on rapid and sustained virological responses   (Citations: 3)
BibTex | RIS | RefWorks Download
Y. Inoue, N. Hiramatsu, T. Oze, T. Yakushijin, K. Mochizuki, H. Hagiwara, M. Oshita, E. Mita, H. Fukui, M. Inada, S. Tamura, H. Yoshiharahttp://academic.research.microsoft.com/io.ashx?type=5&id=31979064&selfId1=0&selfId2=0&maxNumber=12&query=
Journal: Journal of Viral Hepatitis - J VIRAL HEPATITIS , vol. 17, no. 5, pp. 336-344, 2010
Cumulative Annual
View Publication
The following links allow you to view full publications. These links are maintained by other sources not affiliated with Microsoft Academic Search.
    • ...However, there was a trend towards an improved SVR rate in patients with genotype 2. Although previous studies [31, 32] showed that adherence to IFN did not significantly affect the SVR rate in patients with genotype 2/3, improved adherence might increase the SVR rate in patients with genotype 2, for whom, similar to PSE-treated patients, it is considered difficult to achieve an SVR...

    Hiroki TaharaHitoshiet al. A retrospective cohort study of partial splenic embolization for antiv...

Sort by: